arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

TENAX THERAPEUTICS, INC.

TENX

$13.43 ▲ +0.14 (+1.05%) at close

18 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

TENAX THERAPEUTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $526.7M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -45.9% ↘

FCF / Share $-0.91 ↗

Trailing P/E —

Price / Book 1.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-52.60M

↓ -198.8% —

FCF / Share Free cash flow per share

$-0.91

↑ +5.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Apr 30, 2015 10-K ↗	FY 2013 Apr 30, 2014 10-K ↗	FY 2012 Apr 30, 2013 10-K ↗	FY 2011 Apr 30, 2012 10-K ↗	FY 2010 Apr 30, 2011 10-K ↗	FY 2009 Apr 30, 2010 10-K ↗	FY 1966 May 25, 1967 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	-69.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-962%)	-86.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1183%)	227.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2742%)	252.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3058%)	—	—	—
EPS Growth YoY (%)	-16.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	96.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	48.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-2593.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	-198.8% Weak ↓ Weak Declining Year-over-year change in net income	-128.3% Weak ↓ Weak Declining Year-over-year change in net income	30.2% Excellent ↑ Excellent Improving Year-over-year change in net income	66.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-229.6% Weak ↓ Weak Declining Year-over-year change in net income	-17.4% Weak ↓ Weak Declining Year-over-year change in net income	40.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-60.0% Weak Weak Year-over-year change in net income	79.9% Excellent Excellent Year-over-year change in net income	—	—	27.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-107.5% Weak Weak Year-over-year change in net income	40.1% Excellent Excellent Year-over-year change in net income	N/M	—	—	—
FCF Growth YoY (%)	5.9% Fair Fair Year-over-year change in free cash flow	95.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	64.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	66.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	53.2% Excellent Excellent Year-over-year change in free cash flow	-1628.4% Weak Weak Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	—	-48.6% Weak Weak Compound annual revenue growth over 3 years	15.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Apr 30, 2015 10-K ↗	FY 2013 Apr 30, 2014 10-K ↗	FY 2012 Apr 30, 2013 10-K ↗	FY 2011 Apr 30, 2012 10-K ↗	FY 2010 Apr 30, 2011 10-K ↗	FY 2009 Apr 30, 2010 10-K ↗	FY 1966 May 25, 1967 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-435.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3005%)	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-414.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.37x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.69x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.83x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Apr 30, 2015 10-K ↗	FY 2013 Apr 30, 2014 10-K ↗	FY 2012 Apr 30, 2013 10-K ↗	FY 2011 Apr 30, 2012 10-K ↗	FY 2010 Apr 30, 2011 10-K ↗	FY 2009 Apr 30, 2010 10-K ↗	FY 1966 May 25, 1967 10-K ↗
Return on Invested Capital (%)	-45.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-80.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-584.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-609.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	168.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-179.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-81.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-242.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-16.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	230.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	1876.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-224.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-54.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-70.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-324.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-546.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	143.7% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-134.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-93.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-225.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-17.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-163.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-198.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	361.4% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-54.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-461%)	-19.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-95.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-735%)	—	—	-213.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1520%)	-222.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1583%)	-120.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-901%)	-99.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-764%)	-256.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1808%)	—	-20.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-233%)	-23.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-257%)	—	—	-280.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1970%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Apr 30, 2015 10-K ↗	FY 2013 Apr 30, 2014 10-K ↗	FY 2012 Apr 30, 2013 10-K ↗	FY 2011 Apr 30, 2012 10-K ↗	FY 2010 Apr 30, 2011 10-K ↗	FY 2009 Apr 30, 2010 10-K ↗	FY 1966 May 25, 1967 10-K ↗
Interest Coverage (x)	—	-847.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-343.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2487.65x Weak Weak Operating income divided by interest expense Optimal: > 5x	-34487.08x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	-301.88x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.51x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.22x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.11x Weak Weak Operating income divided by interest expense Optimal: > 5x	61.57x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-97.60M	$-94.90M	$-9.80M	$-2.12M	$-5.58M	$-6.25M	$-4.91M	$-12.37M	$-1.60M	$-10.00M	$-3.66M	$-7.93M	$-58.32M	$-783.53K	$-1.88M	$-951.94K	$-632.71K	$0.00

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Apr 30, 2015 10-K ↗	FY 2013 Apr 30, 2014 10-K ↗	FY 2012 Apr 30, 2013 10-K ↗	FY 2011 Apr 30, 2012 10-K ↗	FY 2010 Apr 30, 2011 10-K ↗	FY 2009 Apr 30, 2010 10-K ↗	FY 1966 May 25, 1967 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	—	—	—	—	—	—	—	—	—	$0.00	$0.02	$0.72	$0.28	$0.00	—	—
Basic EPS, GAAP (USD)	$-1.34	$-1.15	$-31.04	—	—	—	—	—	—	—	—	—	—	$-6.29	$-12.12	$-0.45	—	—
Free Cash Flow per Share (USD)	$-0.91	$-0.97	$-23.76	—	—	—	—	—	—	—	—	$-0.35	$-0.99	$-2.99	$-6.40	$-0.37	—	—
Book Value per Share (USD)	$10.42	$26.89	$27.15	$0.65	$3.37	$0.37	$0.56	$3.10	$6.29	$0.61	$2.15	$2.50	$2.98	$-0.92	$-0.24	$-0.16	—	—
Tangible Book Value per Share (USD)	$10.42	$26.89	$27.15	$0.65	$3.37	$0.37	$0.56	$3.10	$6.29	$0.61	$0.97	$1.32	$1.75	$-1.40	$-0.83	$-0.19	—	—
Basic Weighted Avg Shares (shares)	39.22M	15.27M	248,447	—	—	—	—	—	—	—	—	28.08M	9.36M	1.65M	1.30M	23.35M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Apr 30, 2015 10-K ↗	FY 2013 Apr 30, 2014 10-K ↗	FY 2012 Apr 30, 2013 10-K ↗	FY 2011 Apr 30, 2012 10-K ↗	FY 2010 Apr 30, 2011 10-K ↗	FY 2009 Apr 30, 2010 10-K ↗	FY 1966 May 25, 1967 10-K ↗
Working Capital (USD)	$97.07M	$91.99M	$8.10M	$1.36M	$4.13M	$4.68M	$3.65M	$11.75M	$7.05M	$7.43M	$15.96M	$12.99M	$56.39M	$-67.33K	$-495.84K	$-551.03K	—	—
Total Equity (USD)	$97.07M	$91.99M	$8.10M	$1.49M	$4.24M	$4.63M	$3.77M	$11.77M	$8.88M	$17.14M	$60.42M	$70.43M	$82.89M	$-1.78M	$-346.05K	$-3.72M	$2.13M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Apr 30, 2015 10-K ↗	FY 2013 Apr 30, 2014 10-K ↗	FY 2012 Apr 30, 2013 10-K ↗	FY 2011 Apr 30, 2012 10-K ↗	FY 2010 Apr 30, 2011 10-K ↗	FY 2009 Apr 30, 2010 10-K ↗	FY 1966 May 25, 1967 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	—	—	—	—	—	—	—	$0.00	—	$49.29K	$158.93K	$1.19M	$363.78K	$103.17K	—	—
Depreciation Expense (USD)	—	—	—	$5.14K	$4.12K	$4.08K	$5.02K	$9.02K	$13.62K	$18.95K	—	$77.84K	$88.30K	$92.96K	—	—	—	—
Net Income, GAAP (USD)	$-52.60M	$-17.60M	$-7.71M	$-11.05M	$-32.47M	$-9.85M	$-8.39M	$-14.14M	$-8.84M	$-43.92M	—	$-14.08M	$-19.54M	$-9.42M	$-15.71M	$10.45M	—	—
Operating Cash Flow (USD)	$-35.80M	$-14.81M	$-5.90M	$-12.01M	$-10.86M	$-9.27M	$-7.56M	$-5.50M	$-12.14M	$-15.87M	—	$-9.75M	$-9.26M	$-4.92M	$-8.28M	$-8.40M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 70 quarters

TENAX THERAPEUTICS, INC.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TENX with peers